Brief: Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule
11/08/2026 21:02
BRIEF-Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule Aug 11 (Reuters) - Mirum Pharmaceuticals, Inc. MIRM.O:
MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Source text: ID:nBwpHSs6a
Further company coverage: MIRM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mirum Pharmaceuticals
See all newsMirum Pharmaceuticals Q3 net product sales surge, outlook raised
Brief: Mirum Pharmaceuticals Announces Positive Results From Cohort 2 Of The Pivotal Progress Study Of Atebrioz™ (Zilurgisertib) In Pediatric Patients Aged 6 To <12 Years With Fibrodysplasia Ossificans Progressiva
Mirum climbs on positive late-stage trial results for liver disease drug
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX